About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Ptprc
protein tyrosine phosphatase receptor type C
MGI:97810
124 phenotypes from 22 alleles in 27 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Ptprcloc/Ptprcloc
C57BL/6JSfdAnu-Ptprcloc/AnuApb
abnormal B cell number J:104190
abnormal double-positive T cell morphology J:104190
abnormal memory T cell number J:104190
abnormal T cell morphology J:104190
abnormal T cell selection J:104190
abnormal thymocyte activation J:104190
arrested T cell differentiation J:104190
decreased CD4-positive, alpha-beta T cell number J:104190
decreased CD8-positive, alpha-beta T cell number J:104190
decreased double-positive T cell number J:104190
decreased T cell number J:104190
Ptprcltng/Ptprcltng
C57BL/6-Ptprcltng
abnormal T cell differentiation J:158876
decreased CD4-positive, alpha-beta T cell number J:158876
decreased double-positive T cell number J:158876
thymus hypoplasia J:158876
Ptprcltng/Ptprctm1Mak
involves: 129/Sv * C57BL/6
abnormal T cell differentiation J:158876
decreased CD4-positive, alpha-beta T cell number J:158876
decreased double-positive T cell number J:158876
thymus hypoplasia J:158876
Ptprcm1Btlr/Ptprcm1Btlr
involves: C57BL/6J
absent T cells J:152064
Ptprcm1Smv/Ptprcm1Smv
involves: C57BL/6J * C57BL/10J
abnormal CD4-positive T cell differentiation J:214487
abnormal CD8-positive, alpha-beta T cell differentiation J:214487
abnormal immune system cell morphology J:214487
abnormal immune system physiology J:214487
CNS inflammation J:214487
decreased DN4 thymocyte number J:214487
increased DN3 thymocyte number J:214487
increased double-negative T cell number J:214487
increased susceptibility to Herpesvirales infection J:214487
Ptprcm2Btlr/Ptprcm2Btlr
C57BL/6J-Ptprcm2Btlr
abnormal humoral immune response J:216796
decreased B-1a cell number J:216796
decreased B-2 B cell number J:216796
decreased CD4-positive, alpha-beta memory T cell number J:216796
decreased CD8-positive, alpha-beta memory T cell number J:216796
decreased mature B cell number J:216796
decreased memory B cell number J:216796
decreased memory T cell number J:216796
decreased single-positive T cell number J:216796
increased B-1 B cell number J:216796
increased B-1b cell number J:216796
increased dendritic cell number J:216796
increased neutrophil cell number J:216796
increased single-positive T cell number J:216796
Ptprcm3Btlr/Ptprcm3Btlr
C57BL/6J-Ptprcm3Btlr
decreased B cell number J:254899
decreased B-1a cell number J:254899
decreased B-2 B cell number J:254899
decreased CD8-positive, alpha-beta T cell number J:254899
increased B-1b cell number J:254899
Ptprcm4Btlr/Ptprcm4Btlr
C57BL/6J-Ptprcm4Btlr
decreased B cell number J:264808
decreased CD4-positive, alpha-beta T cell number J:264808
decreased CD8-positive, alpha-beta T cell number J:264808
decreased CD8-positive, naive alpha-beta T cell number J:264808
decreased single-positive T cell number J:264808
decreased T cell number J:264808
increased B-1 B cell number J:264808
increased central memory CD4-positive, alpha-beta T cell number J:264808
increased central memory CD8 positive, alpha-beta T cell number J:264808
increased effector memory CD4-positive, alpha-beta T cell number J:264808
increased effector memory CD8-positive, alpha-beta T cell number J:264808
PtprcM5Btlr/PtprcM5Btlr
C57BL/6J-PtprcM5Btlr
increased alpha-beta T cell number J:265143
PtprcM6Btlr/PtprcM6Btlr
C57BL/6J-PtprcM6Btlr
decreased B-1a cell number J:265186
decreased B-1b cell number J:265186
decreased CD8-positive, naive alpha-beta T cell number J:265186
increased B-1 B cell number J:265186
Ptprcm7Btlr/Ptprcm7Btlr
C57BL/6J-Ptprcm7Btlr
decreased alpha-beta T cell number J:267486
decreased B cell number J:267486
decreased CD4-positive, alpha-beta T cell number J:267486
decreased CD8-positive, alpha-beta T cell number J:267486
decreased CD8-positive, naive alpha-beta T cell number J:267486
decreased NK T cell number J:267486
increased B-1 B cell number J:267486
increased central memory CD4-positive, alpha-beta T cell number J:267486
increased central memory CD8 positive, alpha-beta T cell number J:267486
increased effector memory CD4-positive, alpha-beta T cell number J:267486
increased effector memory CD8-positive, alpha-beta T cell number J:267486
PtprcM8Btlr/PtprcM8Btlr
C57BL/6J-PtprcM8Btlr
increased B-1 B cell number J:267487
increased central memory CD8 positive, alpha-beta T cell number J:267487
PtprcM9Btlr/PtprcM9Btlr
C57BL/6J-PtprcM9Btlr
abnormal B cell differentiation J:272745
abnormal CD8-positive, alpha beta T cell morphology J:272745
abnormal lymphocyte morphology J:272745
decreased B cell number J:272745
decreased NK cell number J:272745
decreased systemic arterial systolic blood pressure J:272745
increased CD8-positive, alpha-beta T cell number J:272745
increased effector memory CD4-positive, alpha-beta T cell number J:272745
PtprcM10Btlr/PtprcM10Btlr
C57BL/6J-PtprcM10Btlr
decreased B-1b cell number J:272777
decreased IgE level J:272777
PtprcM11Btlr/PtprcM11Btlr
C57BL/6J-PtprcM11Btlr
abnormal B cell differentiation J:274863
abnormal CD8-positive, alpha-beta T cell differentiation J:274863
increased B-1 B cell number J:274863
Ptprcm12Btlr/Ptprcm12Btlr
C57BL/6J-Ptprcm12Btlr
decreased B cell number J:274972
decreased CD4-positive, alpha-beta T cell number J:274972
decreased CD8-positive, alpha-beta T cell number J:274972
decreased CD8-positive, naive alpha-beta T cell number J:274972
decreased central memory CD8 positive, alpha-beta T cell number J:274972
decreased effector memory CD4-positive, alpha-beta T cell number J:274972
decreased T cell number J:274972
increased B-1 B cell number J:274972
Ptprcnim/Ptprcnim
C57BL/6JAnu-Ptprcnim
decreased B cell number J:225105
decreased leukocyte cell number J:225105
decreased T cell number J:225105
Ptprcrain/Ptprcrain
C57BL/6JAnu-Ptprcrain/AnuApb
abnormal leukocyte morphology J:104190
Ptprcstrm/Ptprcstrm
C57BL/6JAnu-Ptprcstrm/AnuApb
decreased B cell number J:104190
decreased T cell number J:104190
Ptprctm1Holm/Ptprctm1Holm
involves: 129/Sv * C57BL/6
abnormal B cell number J:33466
abnormal lymphopoiesis J:33466
abnormal T cell differentiation J:33466
decreased CD4-positive, alpha-beta T cell number J:33466
decreased CD8-positive, alpha-beta T cell number J:33466
decreased double-positive T cell number J:33466
decreased T cell number J:33466
decreased thymocyte number J:33466
increased double-negative T cell number J:33466
spleen hyperplasia J:33466
Ptprctm1Mak/Ptprctm1Mak
B6.Cg-Ptprctm1Mak
abnormal CD4-positive, alpha-beta intraepithelial T cell morphology J:111646
abnormal intraepithelial T cell morphology J:111646
abnormal intraepithelial T cell number J:111646
abnormal NK cell physiology J:109462
abnormal T cell differentiation J:111646
decreased cytotoxic T cell cytolysis J:111646
decreased gamma-delta intraepithelial T cell number J:111646
increased T cell apoptosis J:111646
Ptprctm1Mak/Ptprctm1Mak
involves: 129
abnormal bone marrow cell morphology/development J:141275
abnormal long bone metaphysis morphology J:141275
abnormal myelination J:104929
abnormal oligodendrocyte morphology J:104929
abnormal osteoclast morphology J:141275
abnormal osteoclast physiology J:141275
decreased mast cell degranulation J:110782
decreased oligodendrocyte number J:104929
decreased susceptibility to type I hypersensitivity reaction J:110782
Ptprctm1Mak/Ptprctm1Mak
involves: 129/Sv * C57BL/6
abnormal response to infection J:13163
abnormal T cell subpopulation ratio J:13163
arrested T cell differentiation J:158876
decreased B cell proliferation J:13163
decreased CD4-positive, alpha-beta T cell number J:13163
decreased CD8-positive, alpha-beta T cell number J:13163
decreased cytotoxic T cell cytolysis J:13163
decreased T cell number J:13163
decreased T cell proliferation J:13163
decreased thymocyte number J:13163
increased double-negative T cell number J:13163
Ptprctm1Tyb/Ptprctm1Tyb
129S2/SvPas-Ptprctm1Tyb
diarrhea J:57681
lethality at weaning, incomplete penetrance J:57681
Ptprctm1Tyb/Ptprctm1Tyb
B6.129S2-Ptprctm1Tyb
abnormal chemokine secretion J:98190
abnormal cytokine secretion J:98190
abnormal NK cell physiology J:98190
increased NK cell number J:98190
Ptprctm1Tyb/Ptprctm1Tyb
C.129S2-Ptprctm1Tyb
abnormal positive T cell selection J:57681
abnormal T cell differentiation J:57681
abnormal T cell physiology J:57681
decreased CD4-positive, alpha-beta T cell number J:57681
decreased CD8-positive, alpha-beta T cell number J:57681
decreased double-positive T cell number J:57681
enlarged spleen J:57681
normal hematopoietic system phenotype J:57681
normal immune system phenotype J:57681
increased double-negative T cell number J:57681
normal mortality/aging J:57681
thymus hypoplasia J:57681
Ptprctm1Tyb/Ptprctm1Tyb
involves: 129S2/SvPas * C57BL/6 * DBA/2
no abnormal phenotype detected J:57681
Ptprctm1Weis/Ptprc+
involves: 129X1/SvJ * C57BL/6
increased anti-double stranded DNA antibody level J:66501
increased IgG2a level J:66501
increased susceptibility to autoimmune disorder J:66501
increased urine protein level J:66501
premature death J:66501
Ptprctm1Weis/Ptprctm1Weis
B6.129X1-Ptprctm1Weis
abnormal B cell activation J:147129
abnormal double-positive T cell morphology J:147129
abnormal follicular B cell physiology J:147129
abnormal T cell activation J:147129
abnormal T cell subpopulation ratio J:147129
abnormal thymocyte activation J:147129
decreased follicular B cell number J:147129
enlarged lymph nodes J:147129
normal immune system phenotype J:109462
increased memory T cell number J:147129
increased plasma cell number J:147129
increased transitional stage B cell number J:147129
liver inflammation J:147129
lung inflammation J:147129
Ptprctm1Weis/Ptprctm1Weis
involves: 129X1/SvJ * C57BL/6
abnormal B cell activation J:66501
abnormal digestion J:66501
abnormal erythropoiesis J:66501
abnormal granulocyte differentiation J:66501
abnormal immune system organ morphology J:66501
abnormal leukocyte cell number J:66501
abnormal T cell activation J:66501
enlarged lymph nodes J:66501
enlarged spleen J:66501
extramedullary hematopoiesis J:66501
glomerulonephritis J:66501
increased anti-double stranded DNA antibody level J:66501
increased B cell number J:66501
increased IgA level J:66501
increased IgG2a level J:66501
increased plasmacytoid dendritic cell number J:66501
increased spleen red pulp amount J:66501
increased spleen white pulp amount J:66501
increased susceptibility to autoimmune disorder J:66501
increased T cell number J:66501
increased urine protein level J:66501
kidney failure J:66501
lymph node hyperplasia J:66501
oliguria J:66501
premature death J:66501

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/09/2024
MGI 6.23
The Jackson Laboratory